The phenomenal success of RNA-based products in tackling the COVID-19 pandemic, globally, as well as their potential to actualize the concept of personalized medicine has resulted in a significant growth in the investment activity in this sector.   Roots Analysis is pleased to announce the publication of its recent study, titled, “Investor Series: Opportunities in the RNA...